Andreas Lysandropoulos grew up around neuroscience and now works to solve unmet needs for patients Andreas Lysandropoulos, MD, Ph.D., joined Parexel Nov. 1 as Global CNS Franchise Leader in...
Learn More
Data privacy has taken on increasing urgency as citizens insist on their right to govern their own data, winning support from governmental and regulatory agencies worldwide. The new EU Clinical...
Learn More
Drug developers and the clinical research community are working to increase diversity, equity, inclusion and belonging within clinical trials. By recruiting diverse patient populations, study...
Learn More
To address critical needs and optimize clinical trial protocols, ask patients what they want most
Learn More
Parexel is the first CRO to be invited to join the Clinical Research Data Sharing Alliance (CRDSA), a year-old organization working to maximize the value of clinical data to make clinical research...
Learn More
Since 2011, the approval of 108 immuno-oncology(I-O) products have radically changed the cancer treatment landscape and the clinical trial pipeline. Rapid development of promising I-O therapies...
Learn More
In November 2021, the U.S. House of Representatives passed a bill under the Build Back Better Act (BBBA) that lays out the first-ever platform for Medicare to negotiate the price of drugs. The...
Learn More
Rachel Smith recently joined Parexel as Executive Director and Head of the Rare Disease, Center of Excellence. During Rachel’s first week, we asked her to share her professional experiences, her...
Learn More
In this blog, Pam Rattananont, Director of Customer Strategy and Innovation at Parexel, shares insights gleaned from her patient accessibility roundtable at the recent 2022 World Orphan Drug...
Learn More
At the end of June 2022, the European Commission organized a meeting about the Regulation (EU) 2021/2282 on Health Technology Assessment (HTA) with all stakeholders in the European healthcare...
Learn More
The U.S. Food and Drug Administration (FDA) has long aimed to strengthen its use of remote inspection and integrate desk-based assessments with traditional on-site visits. The pandemic has...
Learn More
The U.S. Food and Drug Administration (FDA) has long aimed to strengthen its use of remote inspection and integrate desk-based assessments with traditional on-site visits. The pandemic has...
Learn More
Cancer thriver and rare disease care partner Stacy Hurt is Parexel’s first Patient Ambassador and “secret weapon” to develop patient-centric clinical trials.
Learn More
Clinical research lacks workers — but in FSP, we’re training the professionals we need
Learn More
As decentralized trials gain prevalence, clinical supply chains can flex to meet new needs.
Learn More
Just because the COVID pandemic disrupted business operations, the importance of data integrity in manufacturing has not diminished. Accurate data is the foundation of product quality. How can...
Learn More
Over the past decade, there has been a proliferation of real-world data (RWD) sources that sponsors can use to generate real-world evidence (RWE) for a wide range of purposes across the product...
Learn More
Julie has spent more than 25 years advocating for patients with chronic diseases, both professionally and personally. She has extensive experience in recruiting, engaging, and retaining patients...
Learn More
Empowered patients are the touchstone of modern healthcare. Yet, in a highly regulated industry, with scores of stakeholders, novel scientific questions and methodologies, emerging technologies...
Learn More
Across the clinical research community, we’re working toward creating more inclusive studies. By recruiting and supporting patients from underrepresented communities, we help ensure equitable...
Learn More
Loading More...
